Related Experiment Videos
Imipenem-cilastatin
1Department of Obstetrics and Gynecology, Medical College of Virginia, Virginia Commonwealth University, Richmond.
Abstract:
Imipenem-cilastatin, with its broad spectrum of activity and relative safety, offers an excellent alternative for the treatment of many obstetric and gynecologic infections. In addition, the possibilities for intramuscular administration give clinicians additional treatment options. Because of the relatively high cost of imipenem-cilastatin, it should not be considered "first-line" therapy for most obstetric and gynecologic infections at present. Misuse and overuse of imipenem-cilastatin will result in the further development of resistant organisms, as has already been seen with many other antibiotics, and continued monitoring of susceptibility patterns is necessary.
Insights
Imipenem-cilastatin is a safe antibiotic for obstetric and gynecologic infections, offering intramuscular options. However, its high cost and risk of resistance mean it
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Pharmacology
Background:
- Imipenem-cilastatin presents broad-spectrum antimicrobial activity.
- It is considered relatively safe for patient use.
- Intramuscular administration offers flexible treatment options.
Purpose of the Study:
- To evaluate imipenem-cilastatin as a treatment for obstetric and gynecologic infections.
- To discuss its potential role and limitations in clinical practice.
Main Methods:
- Literature review of imipenem-cilastatin's efficacy and safety.
- Analysis of its pharmacokinetic properties, including intramuscular administration.
- Consideration of cost-effectiveness and antimicrobial resistance patterns.
Main Results:
- Imipenem-cilastatin demonstrates broad-spectrum activity and safety in obstetric and gynecologic settings.
- Intramuscular administration provides a viable alternative route.
- High cost currently precludes its use as a first-line agent.
Conclusions:
- Imipenem-cilastatin is a valuable therapeutic option for specific obstetric and gynecologic infections.
- Judicious use is essential to mitigate the development of antibiotic resistance.
- Ongoing surveillance of susceptibility patterns is crucial for effective antimicrobial stewardship.